טוען...
Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma
BACKGROUND: Glioma O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status informs clinical decision making. Worldwide different methods and cutoff levels are used, which can lead to discordant methylation results. METHODS: We conducted an international survey to clarify which meth...
שמור ב:
| הוצא לאור ב: | Neurooncol Pract |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6993038/ https://ncbi.nlm.nih.gov/pubmed/32025325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz039 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|